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Objective: Virtual bronchoscopy is a novel technique making use of 3-dimensional
reconstruction of 2-dimensional helical computed tomographic images for nonin-
vasive evaluation of the tracheobronchial tree. This study was undertaken to
evaluate the diagnostic potential of virtual bronchoscopy by comparing virtual
bronchoscopic images with fiberoptic bronchoscopic findings in patients with tho-
racic malignant disease.
Methods: Thirty-two consecutive patients with thoracic malignant tumors under-
went virtual bronchoscopy for evaluation of suspected tracheobronchial lesions. For
each virtual bronchoscopic examination, 200 to 300 contiguous 1.25-mm images of
the thorax were obtained in only one or two 17-second breath holds by using a
multislice computed tomographic scanner. Virtual bronchoscopy images were re-
constructed and interpreted blind to the actual endoscopic findings. Results of
virtual bronchoscopy were compared with fiberoptic bronchoscopic findings in 20
patients.
Results: Anatomic computer simulation of the bronchial tree was successfully
created in all patients. In 7 (35%) of 20 patients, results of fiberoptic bronchoscopy
were found to be within normal limits. In all patients with normal anatomy, virtual
bronchoscopy accurately correlated with the fiberoptic findings. Thirteen (65%)
patients had a total of 22 abnormal findings on fiberoptic bronchoscopy. Virtual
bronchoscopy detected 18 of 22 abnormal fiberoptic bronchoscopic findings: 13 of
13 obstructive lesions, 5 of 6 endoluminal lesions, and 0 of 3 mucosal lesions. The
sensitivity of virtual bronchoscopy was 100% for obstructive lesions, 83% for
endoluminal lesions, 0% for mucosal lesions, and 82% for all abnormalities; the
specificity of virtual bronchoscopy was 100%.
Conclusions: Preliminary evaluation indicates that virtual bronchoscopy may be a
promising and noninvasive modality for identifying bronchial obstructions and
endoluminal lesions, as well as for assessing the tracheobronchial tree beyond
stenoses. However, at present, virtual bronchoscopy does not enable the detection of
subtle mucosal lesions, and as such, this modality may not be appropriate for
identifying premalignant lesions in the respiratory tract. Although fiberoptic bron-
choscopy remains the standard modality for evaluating airway patency and mucosal
lesions, virtual bronchoscopy may provide additional information that may be useful
in the management of pulmonary malignant tumors.
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Virtual bronchoscopy (VB) is a novel tech-nique making use of 3-dimensional (3-D)reconstruction of high-resolution helicalcomputed tomographic (CT) images fornoninvasive evaluation of the tracheo-bronchial tree. VB involves perspective
surface or volume rendering of 2-dimensional (2-D) CT
scan images to construct endoscopic-like visualization of
the airway.1 Because patients with malignant tumors of the
thorax frequently have complete bronchial obstructions
caused by endoluminal tumors and extrinsic compression, a
noninvasive, reproducible, and objective method for se-
quentially evaluating these abnormalities might prove use-
ful in guiding therapy and assessing treatment response in
these individuals.2
Patients with mediastinal and central pulmonary lesions
typically undergo conventional CT scanning of the chest,
followed by fiberoptic bronchoscopy (FB).3 CT generates
2-D cross-sectional images of the thorax to provide infor-
mation regarding peribronchial anatomy. In the evaluation
of major endobronchial disease, CT scans have a sensitivity
of 63% to 100% and a specificity of 61% to 99%.4-6 Sub-
optimal scanning techniques, inappropriate slice thickness,
and artifacts between sections may limit the accuracy of
airway anatomy defined by conventional CT scans.7 FB
remains the best modality for evaluation of endoluminal and
mucosal lesions; however, endoscopy yields no information
about the extent of extraluminal disease or airway patency
distal to a high-grade stenosis.8 In addition, FB poses a
potential risk to the patient (morbidity 0.8%) because some
degree of sedation is required9; this risk may be increased in
patients with advanced intrathoracic disease.
VB, also referred to as computerized tomographic bron-
chography, uses noninvasive high-resolution CT techniques
exploiting the natural contrast between the air in the tra-
cheobronchial tree and the soft tissue of the airway wall to
establish a plane for generating the virtual airway6; the
images are used to generate a 3-D model of airway anatomy.
Once the virtual airway is created, the viewer can navigate
through the airway in a 3-D manner analogous to standard
FB. In addition, VB allows for unconventional images, such
as retrograde views of endoluminal and extraluminal anat-
omy.8 The airway can be manipulated in space and evalu-
ated from multiple angles.
In the present study we sought to examine the utility of
VB relative to conventional diagnostic modalities in tho-
racic oncology patients. Herein we report that VB is an
excellent, reproducible, and noninvasive modality that can
be used to image tracheobronchial lesions, thus enabling
sequential evaluation of treatment response in patients with
malignant disease of the thorax. In addition, VB may be
helpful in selecting patients for segmental lung resections or




Thirty-two consecutive patients with thoracic malignant disease
were prospectively enrolled in institutional review board-approved
National Institutes of Health (NIH) Protocol 96-CC-0021 and
evaluated by means of VB between November 19, 1999, and
January 2, 2001. Inclusion criteria were the presence of a malig-
nant tumor of the thorax and willingness to undergo investigational
imaging at the NIH. Informed consent was obtained from each
participant. After VB images had been successfully acquired in 10
patients, an additional 22 individuals were accrued, with the intent
of obtaining correlative FB images within 2 weeks of VB. Two of
these 22 patients were subsequently excluded from analysis be-
cause correlative bronchoscopy was not obtained within 2 weeks
after VB. The mean age of all patients was 54 years (median age,
54 years; SD, 12 years; age range, 29-88 years). Of these 32
patients, 23 (72%) were men (mean age, 54 years; median age, 57
years; SD, 11 years; range, 33-88 years), and 9 (28%) were
women (mean age, 52 years; median, 51 years; SD, 15 years;
range, 29-79 years). Histologic diagnoses included non-small cell
lung cancer (n  12), small cell lung cancer (n  3), metastatic
renal cell cancer (n  8), metastatic melanoma (n  5), metastatic
thyroid cancer (n  2), sarcoma (n  1), and esophageal cancer
(n  1).
Examination Technique
For each FB, visualization of the tracheobronchial tree was
achieved under the direction of the attending thoracic surgeons
(D.S.S. and D.M.N.), who were blinded to results of VB. FB
findings that were entered into the database included the presence
or absence of obstructive lesions (defined as bronchial narrowing
of 50%), endoluminal masses (defined as a mass protruding into
the lumen with50% occlusion), or mucosal lesions (hemorrhage,
erythema, or tissue friability).
For each VB, 200 to 300 contiguous 1.25-mm images of the
thorax were obtained in only one or two 17-second breath holds by
using a multislice helical CT scanner (G.E. LightSpeed QX/i,
Milwaukee, Wis).10 The technique was 1.25 collimation, HS mode
(helical pitch 6, 7.5-mm table motion per rotation, 120 kVp, 100
mAs, 0.8-second tube rotation, nonoverlapping reconstructions
with a section interval of 1.25 mm and an effective z-axis resolu-
tion of approximately 1.6 mm). The manufacturer’s standard re-
construction algorithm was used. The multiple scan average dose
to the scanned volume was 1.58 rad at the surface and 0.78 rad in
the center per examination. Radiation exposure from VB was
calculated to be the same or slightly less than that with a conven-
tional thoracic CT scan (James Vucich, Medical Physicist, NIH).
3-D Reconstruction and Analysis
VB images were reconstructed to 3-D endoscopic views by using
commercial software (G.E. Navigator on a G.E. Advantage Win-
dows workstation). The radiologist (R.M.S.) first placed the view-
point in the proximal trachea. Retrograde inspection of the sub-
glottis was done. The following were reviewed sequentially:
antegrade inspection of the trachea, right main stem bronchus,
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right upper lobe apical B1, right upper lobe posterior B2, right
upper lobe anterior B3, bronchus intermedius, right middle lobe,
right middle lobe lateral B4, right middle lobe medial B5, right
lower lobe superior B6, right lower lobe medial basal B7, right
lower lobe anterior basal B8, right lower lobe lateral basal B9,
right lower lobe posterior basal B10, left main stem bronchus, left
upper lobe, left upper lobe superior division, left upper lobe apical
posterior B12, left upper lobe anterior B3, lingular, left upper
lobe superior lingular B4, left upper lobe inferior lingular B5, left
lower lobe superior B6, left lower lobe anteromedial basal B7-8,
left lower lobe lateral basal B9, and left lower lobe posterior basal
B10.
Abnormalities in the tracheobronchial tree were recorded. The
radiologist interpreted all VB images blind to the actual FB results.
The presence or absence of obstructive lesions (defined as bron-
chial narrowing of50%), endoluminal masses (defined as a mass
protruding into the lumen with 50% occlusion), or mucosal
lesions (hemorrhage, erythema, or tissue friability) were entered
into the database.
The results of VB were compared with actual FB findings at the
same anatomic sites. True-positive (TP) results occurred when VB
equaled FB when FB visualized a lesion. True-negative (TN)
results occurred when VB equaled FB when FB was within normal
limits. False-negative (FN) results occurred when VB failed to
detect a lesion documented during FB. False-positive (FP) results
occurred when VB demonstrated an abnormality, but FB revealed
the area to be normal. Sensitivity (TP/[TPFN]) and specificity
(TN/[TNFP]) of VB were computed.
Results
Anatomic computer simulation of the bronchial tree was
successfully created in all patients. There were no signifi-
cant respiratory or cardiac motion artifacts precluding 3-D
image reconstruction. Of the 20 patients who had correlative
FBs, 7 (35%) had normal examination results (Figure 1). In
all patients with normal anatomy, results of VB accurately
correlated with results of FB.
Thirteen (65%) patients had a total of 22 abnormal FB
findings. VB detected 18 of these 22 abnormalities, includ-
ing 13 of 13 obstructive lesions, 5 of 6 endoluminal masses,
and 0 of 3 mucosal lesions (Figures 2 and 3). VB did not
reveal 4 abnormalities identified during FB: a small periph-
eral endoluminal mass in 1 patient, benign mucosal inflam-
mation after induction chemotherapy (which resolved
within 2 weeks) in 1 patient, and the presence of blood in 2
patients (with no evidence of distal endobronchial lesions).
However, VB revealed 7 obstructive lesions that were not
visualized by means of FB because of size limitation of the
bronchoscope (5 patients) and lesions beyond stenoses (2
patients, Table 1). Overall, the sensitivity of VB was 100%
for obstructive lesions, 83% for endoluminal masses, 0% for
mucosal lesions, and 82% for all abnormalities; the speci-
ficity of VB was 100%.
Discussion
Standard preoperative diagnostic procedures in patients
with malignant disease of the thorax include CT scanning of
the chest and FB. Although these methods are highly reli-
able, both have technical limitations that may lead to inac-
curate characterization of airway pathology. With advances
in medical imaging, multislice helical CT scanners allow for
3-D reconstruction of tracheobronchial anatomy without an
increase in radiation exposure.
Fleiter and colleagues11 reported a series of patients with
thoracic malignant disease who underwent VB with a dou-
ble-detector CT unit and correlative FB. VB images were
successfully created in 19 of 20 patients. In one patient a
strong heart pulsation produced a motion artifact that pre-
vented accurate reconstruction. Sites of high-grade stenosis
were accurately detected with both techniques. VB allowed
for accurate anatomic visualization beyond stenoses. Dis-
crete malignant infiltration and extraluminal compression
were not visualized by means of VB in 5 patients. Liewald
and coworkers12 evaluated 30 patients with lung cancer
using VB and FB. Three-dimensional images were created
in all patients. Thirteen obstructive lesions were seen
equally well with VB and FB. VB delineated tracheobron-
chial anatomy beyond high-grade stenosis in 2 patients.
However, mucosal lesions were not visualized by means of
VB.12 Rapp-Bernhardt and associates13 compared VB with
FB in 21 patients with esophageal carcinoma infiltrating the
tracheobronchial tree. These authors found no statistically
significant difference in the location or grading of stenoses
when comparing VB with FB. These same authors also
Figure 1. VB of normal anatomy. Viewpoint is in trachea above
carina looking into right and left main stem bronchi.
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evaluated 18 patients with bronchogenic carcinoma. CT and
VB were used to evaluate tracheobronchial stenoses that
had been detected by means of FB. CT of the chest was
found to have a sensitivity of 92.9% and a specificity of
100%. VB was found to have a sensitivity of 93.8% and a
specificity of 99.7%.14
Our experience confirms that of previous investigators
who have evaluated the feasibility and utility of VB in
patients with primary or metastatic cancers involving the
lungs and mediastinum. We noted that the sensitivity of VB
was 100% for obstructive stenotic lesions and that VB was
effective for visualizing obstructive lesions in poststenotic
sites. VB was also effective at detecting peripheral obstruc-
tive lesions beyond the size limits of the endoscope in 5
patients. Our study demonstrated that VB had an overall
sensitivity of 82% for detecting any abnormality in the
tracheobronchial tree. VB was not effective for detection of
subtle mucosal abnormalities, including erythema and tissue
friability. It is important to note that VB was able to detect
5 of 6 endoluminal lesions. This represents the first report
Figure 2. A, VB; B, FB. Endoluminal lesion in a 51-year-old man with metastatic renal cell carcinoma to the right
hilum. The lesion consists of both large and small components in the right main stem bronchus (arrows) with
complete obstruction of the right upper lobe bronchus. Note corresponding morphology at VB compared with at FB.
Figure 3. A, VB; B, FB. Normal anatomy beyond poststenotic area. Viewpoint is in right lower lobe bronchus looking
toward right lower lobe segmental bronchi.
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that VB may be useful for reliably detecting endoluminal
disease not advanced enough to cause atelectasis or distal
pneumonitis detectable by conventional imaging tech-
niques. Hence this modality may be helpful in guiding
bronchoscopic evaluation of patients with intermittent he-
moptysis.
There are several advantages of VB. The technique is
noninvasive, and no additional radiation exposure occurs
relative to standard CT scans of the chest. Commercial
software allows for the seamless interactivity of 2-D and
3-D images, thereby enhancing the detection of extralumi-
nal and intraluminal disease. Indeed, for every endoluminal
position of the virtual endoscope, it is possible to refer to the
corresponding cross-sectional images or to other multipla-
nar reconstructions to evaluate structures outside the bron-
chial lumen that may have clinical significance. Although
this issue was not specifically addressed in the present
study, interpretation of VB by radiologists, thoracic sur-
geons, and pulmonologists should be highly reproducible
and reliable, given the objectivity of the imaging techniques
and the software used for data analysis. As such, VB may
prove to be a highly effective, objective, and reproducible
means of assessing treatment response in patients enrolled
in clinical protocols. Furthermore, because VB provides
accurate information regarding the length of obstructing
lesions and the anatomy distal to an obstruction, this mo-
dality may prove to be useful for assessing the feasibility of
anatomic segmentectomy, as well as that of endobronchial
laser or photodynamic therapy, in thoracic oncology pa-
tients.
One limitation of VB pertains to the inability to evaluate
the mucosal surface of the tracheobronchial tree. Although
form can be detected, mucosal color, irregularity, or fria-
bility cannot be assessed. Hence at present VB may not be
a reliable modality for the detection of premalignant tra-
cheobronchial lesions. However, with continued refine-
ments in acquisition capabilities and image display tech-
niques, such as high-resolution ultrasonography, magnetic
resonance imaging, or positron emission tomography scan-
ning, it may soon be possible to evaluate the mucosal
surface by means of VB. If this occurs, VB may prove to be
an efficient modality for early detection of airway malignant
tumors and for assessing response in patients enrolled in
chemoprevention protocols. However, because VB does not
enable acquisition of tissue samples for histologic or micro-
biologic analysis, this modality will never completely re-
place FB for evaluation of lesions in the respiratory tract.
As technology advances, we must justify clinical indica-
tions for new and potentially expensive methods. Our cur-
rent study indicates that VB is an accurate and noninvasive
method for evaluating obstructions, endoluminal masses,
and poststenotic areas within the airway. Although FB re-
mains the best modality for examining airway patency and
mucosal lesions, VB yields additional information regard-
ing bronchial anatomy that may prove useful in the man-
agement of patients with malignant disease of the thorax.
TABLE 1. Comparison of VB findings with FB findings in 20 patients with thoracic malignancy
Patient
No. Age (y) Sex Diagnosis VB results FB results
1 49 M Sarcoma O NV
2 38 F Melanoma E E
3 58 M NSCLC E, O, O, O E, O, O, O
4 44 M NSCLC N N
5 53 F NSCLC O NV, M
6 40 F Melanoma O, O O, O
7 44 F RCC E, O E
8 66 M Melanoma N, N M, E
9 69 M NSCLC N N
10 40 F NSCLC O NV
11 88 F NSCLC O, O O, NV
12 44 M RCC N M
13 58 M RCC O, O NV, NV
14 73 M NSCLC N N
15 56 M RCC E, O E, O
16 50 M RCC O O
17 64 M RCC N N
18 59 M SCLC O O
19 52 M RCC E, O E, O
20 54 F NSCLC O, O, O O, O, O
Letters in bold indicate lesions visualized by VB but not by FB. Underlined and italicized letters indicate lesions visualized by FB but not by VB. O, Obstructive
lesion (defined as bronchial narrowing of 50%); NV, not visible because of technical issues; E, endoluminal mass (defined as a mass protruding into the
lumen with 50% obstruction); N, within normal limits; M, mucosall lesion (defined as hemorrhage, erythema, abnormal color, or tissue friability).
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